Description: Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.
Home Page: www.arcutis.com
ARQT Technical Analysis
3027 Townsgate Road
Westlake Village,
CA
91361
United States
Phone:
805 418 5006
Officers
| Name | Title |
|---|---|
| Mr. Todd Franklin Watanabe M.A. | Pres, CEO & Director |
| Dr. Bhaskar Chaudhuri Ph.D. | Co-Founder & Independent Director |
| Mr. Scott L. Burrows | CFO & Principal Accounting Officer |
| Dr. David W. Osborne Ph.D. | Chief Technical Officer |
| Dr. Patrick E. Burnett M.D., Ph.D. | Sr. VP & Chief Medical Officer |
| Mr. Matthew Richard Moore | Sr. VP & Chief Bus. Officer |
| Ms. Patricia A. Turney | Sr. VP of Operations |
| Mr. Eric McIntyre | Head of Investor Relations |
| Ms. Courtney Barton | VP and Chief Compliance Officer & Privacy Officer |
| Mr. Masaru Matsuda Esq., J.D. | Sr. VP, Gen. Counsel & Corp. Sec. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.742 |
| Price-to-Sales TTM: | 1385.7922 |
| IPO Date: | 2020-01-31 |
| Fiscal Year End: | December |
| Full Time Employees: | 147 |